Short description
BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.
Description
BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Durham, North Carolina, United States, North America
Founded on
January 1, 1994
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Uh Ohhhh, Noaccessforu, Noaccessforu, Noway Youcantaccess
Sign in for full access
Founders
Karl Tryggvason
Funding rounds count
1
Portfolio organisations count
Absolutely Noaccess, Nopepepe
Sign in for full access
Exits count
Noaccess, Blurry Noaccess
Sign in for full access
IPO exits count
1